This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Study: Radical Prostatectomy Bests Radiation For Prostate Cancer

NEW YORK, Jan. 11, 2013 /PRNewswire/ -- A comparative review of more than 230 previously published studies bumps radical prostate removal surgery above radiation in cost-effectiveness, quality of life after treatment, and patient survival. Surgery, whether performed traditionally, laparoscopically, or robotically, demonstrated improved outcomes across all three factors when compared to radiation for prostate cancer in the form of intensity-modulate radiation therapy, brachytherapy, or a combination of the two. 

(Photo:  http://photos.prnewswire.com/prnh/20130111/NY40649 )

Dr. David Samadi, Vice Chairman, Department of Urology, and Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center believes these findings will be instrumental in shaping prostate cancer treatment decisions among newly diagnosed patients. "The comprehensive nature of this study gives very meaningful support to patients weighing prostate cancer treatment options," he said. "This data demonstrates that prostatectomy surgery saves money and lives. That verification, combined with the unique results of my SMART (Samadi Modified Advanced Robotic Technique) surgery, makes robotic surgery a superior choice for patients, their families, and the healthcare system."

Featured in the British Journal of Urology International (see http://onlinelibrary.wiley.com/doi/10.1111/j.1464-410X.2012.11597.x/abstract), the findings were compiled using a Markov model with data from previously published studies on treatment expenses and outcomes for patient with low-, intermediate-, and high-risk prostate cancer. In almost all cases, radial prostatectomy—regardless of surgical method—proved more effective and less costly than radiation. An exception was noted in high-risk patients who underwent a combination of external beam radiation therapy (EBRT) and brachytherapy. According to Dr. Samadi, "High-risk patients are likely to have prostate cancer that has spread beyond the prostate and, therefore, would not be considered surgical candidates."

Notably, in the case of low-risk prostate cancer, intensity-modulated radiation therapy proved less effective and more expensive than radical prostatectomy surgery. In fact, a review of the financial impact on the patient and the payer, found radiation therapy to be consistently more expensive than surgery. Lifetime costs of the disease, including any necessary follow-up or salvage treatment, were statistically and clinically comparable across surgical methods, though significantly varied among radiation patients.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,928.20 -142.20 -0.79%
S&P 500 2,089.46 -25.03 -1.18%
NASDAQ 4,939.3270 -77.6020 -1.55%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs